These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30638952)

  • 1. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
    Luo HS; Wu DH
    Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
    Xue J; Jia E; Ren N; Xin H
    Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
    Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
    BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
    Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
    Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma-derived Exosomal miR-25-3p and miR-23b-3p as Predictors of Response to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.
    Jing Z; Guo Z; Zhang C
    Technol Cancer Res Treat; 2024; 23():15330338241289520. PubMed ID: 39380461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
    Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
    Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
    Wang Y; Fang Q; Tian L; Yuan Z; Tian L; Zhou Z
    Technol Cancer Res Treat; 2020; 19():1533033820920967. PubMed ID: 32356485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
    Suzuki S; Yokobori T; Tanaka N; Sakai M; Sano A; Inose T; Sohda M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Oncol Rep; 2012 Aug; 28(2):465-72. PubMed ID: 22641236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
    Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC.
    Tian Z; Li Z; Zhu Y; Meng L; Liu F; Sang M; Wang G
    Clin Exp Metastasis; 2019 Aug; 36(4):381-391. PubMed ID: 31197517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
    Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H
    Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
    Yang H; Chen Y; Huang X; Gu Y; Chen Z; Mao W
    Int J Med Sci; 2024; 21(7):1213-1226. PubMed ID: 38818465
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and validation of hub microRNAs dysregulated in esophageal squamous cell carcinoma.
    Sang C; Chao C; Wang M; Zhang Y; Luo G; Zhang X
    Aging (Albany NY); 2020 May; 12(10):9807-9824. PubMed ID: 32412911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
    Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
    Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.